ID | 69431 |
FullText URL | |
Author |
Nishimura, Shingo
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Inoue, Shota
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sekito, Takanori
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic
Tsuboi, Ichiro
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tokunaga, Moto
Department of Urology, NHO Okayama Medical Center
Yoshinaga, Kasumi
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Maruyama, Yuki
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic
Mitsui, Yosuke
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Yamanoi, Tomoaki
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kawada, Tatsushi
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kubota, Risa
Department of Urology, NHO Okayama Medical Center
Sadahira, Takuya
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
researchmap
Tominaga, Yusuke
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Iwata, Takehiro
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
Katayama, Satoshi
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Bekku, Kensuke
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Edamura, Kohei
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Wada, Koichiro
Department of Urology, Shimane University Faculty of Medicine
Kobayashi, Yasuyuki
Department of Urology, Hiroshima City Hiroshima Citizens Hospital
Araki, Motoo
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
|
Abstract | Background/Objectives: Limited research exists on risk factors for urinary tract infections (UTIs) in kidney transplant recipients, particularly in high-risk groups such as ABO-incompatible or donor-specific antibody (DSA)-positive cases. Early UTIs, especially within the first month post-transplant, impact on acute rejection and long-term graft outcomes, highlighting the need for risk factor identification and management. Methods: Among 157 living donor kidney transplant cases performed at our institution between 2009 and 2024, 128 patients were included after excluding cases with >72 h of perioperative prophylactic antibiotics or urological complications. UTI was defined as the presence of pyuria and a positive urine culture, accompanied by clinical symptoms requiring antibiotic treatment, occurring within one month post-transplantation. Results: The median onset of UTI was postoperative day 8 (interquartile range, IQR: 6.8–9.3). No subsequent acute rejection episodes were observed. The median serum creatinine at 1 month postoperatively was 1.3 mg/dL (IQR: 1.1–1.7), and this was not significantly different from those who did not develop UTI. In univariate analysis, low or high BMI (<20 or >25), longer dialysis duration (>2.5 years), desensitization therapy (plasmapheresis + rituximab), elevated preoperative neutrophil-to-lymphocyte ratio (NLR) (≥3), and longer warm ischemic time (WIT) (≥7.8 min) were significantly associated with an increased infection risk of UTI (p = 0.010, 0.036, 0.028, 0.015, and 0.038, respectively). Multivariate analyses revealed that abnormal BMI, longer dialysis duration, desensitization therapy, and longer WIT were independent risk factors for UTI (p = 0.012, 0.031, 0.008, and 0.033, respectively). The incidence of UTI increased with the number of risk factors: 0% (0/16) for zero, 10% (5/48) for one, 31% (16/51) for two, 45% (5/11) for three, and 100% (2/2) for four risk factors. Conclusions: Desensitization therapy, BMI, dialysis duration, and WIT were identified as independent risk factors for perioperative UTI. In patients with risk factors, additional preventive strategies should be considered, with extended antibiotic prophylaxis being one potential option.
|
Keywords | living donor kidney transplantation
urinary tract infection
perioperative
desensitization
rituximab
plasmapheresis
body mass index
dialysis duration
warm ischemic time
prophylactic antimicrobials
|
Published Date | 2025-08-28
|
Publication Title |
Journal of Clinical Medicine
|
Volume | volume14
|
Issue | issue17
|
Publisher | MDPI AG
|
Start Page | 6102
|
ISSN | 2077-0383
|
Content Type |
Journal Article
|
language |
English
|
OAI-PMH Set |
岡山大学
|
Copyright Holders | © 2025 by the authors.
|
File Version | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
Related Url | isVersionOf https://doi.org/10.3390/jcm14176102
|
License | https://creativecommons.org/licenses/by/4.0/
|
Citation | Nishimura, S.; Inoue, S.; Sekito, T.; Tsuboi, I.; Tokunaga, M.; Yoshinaga, K.; Maruyama, Y.; Mitsui, Y.; Yamanoi, T.; Kawada, T.; et al. Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center Analysis. J. Clin. Med. 2025, 14, 6102. https://doi.org/10.3390/jcm14176102
|